These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11272278)

  • 1. Differences in the induction of CD8+ T cell responses by subpopulations of dendritic cells from afferent lymph are related to IL-1 alpha secretion.
    Hope JC; Sopp P; Collins RA; Howard CJ
    J Leukoc Biol; 2001 Feb; 69(2):271-9. PubMed ID: 11272278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two distinct populations of dendritic cells in afferent lymph that vary in their ability to stimulate T cells.
    Howard CJ; Sopp P; Brownlie J; Kwong LS; Parsons KR; Taylor G
    J Immunol; 1997 Dec; 159(11):5372-82. PubMed ID: 9548477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses.
    Rückert R; Brandt K; Bulanova E; Mirghomizadeh F; Paus R; Bulfone-Paus S
    Eur J Immunol; 2003 Dec; 33(12):3493-503. PubMed ID: 14635060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells.
    Wirths S; Reichert J; Grünebach F; Brossart P
    Cancer Res; 2002 Sep; 62(17):5065-8. PubMed ID: 12208762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo.
    Roberts JM; Yang J; Ronchese F
    Int Immunol; 2004 Oct; 16(10):1451-8. PubMed ID: 15326095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol consumption modifies dendritic cell antigen presentation in mice.
    Heinz R; Waltenbaugh C
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells.
    Carbonneil C; Saidi H; Donkova-Petrini V; Weiss L
    Int Immunol; 2004 Jul; 16(7):1037-52. PubMed ID: 15184347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
    Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
    Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
    J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced antigen concentration and costimulatory blockade increase IFN-gamma secretion in naive CD8+ T cells.
    Hall HT; Petrovic J; Höglund P
    Eur J Immunol; 2004 Nov; 34(11):3091-101. PubMed ID: 15384046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of the signals regulating CD8 T cell proliferative responses to CD8alpha+ or CD8alpha- dendritic cells.
    Winkel KD; Kronin V; Krummel MF; Shortman K
    Eur J Immunol; 1997 Dec; 27(12):3350-9. PubMed ID: 9464823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
    Boyman O; Kovar M; Rubinstein MP; Surh CD; Sprent J
    Science; 2006 Mar; 311(5769):1924-7. PubMed ID: 16484453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) T cells stimulate memory CD8(+) T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretion.
    Shi M; Hao S; Chan T; Xiang J
    J Leukoc Biol; 2006 Dec; 80(6):1354-63. PubMed ID: 16980510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS; Lattime EC
    Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell response.
    Breckpot K; Corthals J; Bonehill A; Michiels A; Tuyaerts S; Aerts C; Heirman C; Thielemans K
    J Leukoc Biol; 2005 Oct; 78(4):898-908. PubMed ID: 16037410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.